Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 245

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 245
---
 risk oversight strategy.

Despite our efforts to improve our cybersecurity
measures, there can be no assurance that our initiatives will fully mitigate the risks posed by cyber threats. The landscape of cybersecurity
risks is constantly evolving, and we will continue to assess and update our cybersecurity measures in response to emerging threats.

For a discussion of potential cybersecurity risks
affecting us, please refer to the “Risk Factors” section of our Registration Statement on Form S-1 filed with the Securities
and Exchange Commission on February 14, 2025 titled “Cybersecurity risks could adversely affect our business and disrupt our
operations.”

Item 2. Properties.

Our corporate headquarters are located at 1025
Connecticut Avenue NW Suite 1000, Washington, D.C. 20036. We do not own any physical property, plant or labs. We currently lease one
office at the above address and in December 2024, we renewed our lease for an additional one-year term that expires March 31, 2026.

Item 3. Legal Proceedings.

From time to time, we may become involved in
various claims and legal proceedings. We are not currently a party to any legal proceedings that, in the opinion of our management, are
likely to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because
of defense and settlement costs, diversion of management resources and other factors.

Item 4. Mine Safety Disclosures.

Not applicable.

40

PART
II

Item 5. Market for Registrant’s
Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock is currently listed on The Nasdaq Capital Market under
the symbol “SXTP,” and warrants under the symbol “SXTPW.” Trading in our common stock has historically lacked
consistent volume, and the market price has been volatile.

On March 26, 2025 the closing price for our common
stock and warrants as reported on The Nasdaq Capital Market was $1.88 per share and $0.024, respectively.

Holders of Common Stock

On March 27, 2025, there were 21 holders of record of our common stock.

Reverse Stock Split

On November 6, 2024, our Board approved a reverse
stock split of our Common Stock at a split ratio ranging between 1:3 and 1:5, as determined by the Board in its sole discretion. On November